Microbial tryptophan metabolites produced by gut bacteria through the third branch of tryptophan metabolism — the indole pathway. Unlike the host-dominated kynurenine pathway (~95% of Trp) and the serotonin pathway (~1-2%), the indole pathway is exclusively microbial and produces ligands for the aryl hydrocarbon receptor (AhR), a master regulator of mucosal immunity and barrier function.
Key Indole Metabolites
Indole
- Direct deamination product of tryptophan by bacterial tryptophanase (TnaA), expressed by E. coli, Bacteroides, Clostridium.
- Strengthens epithelial barrier via pregnane X receptor (PXR) activation; increases tight junction protein expression.
Indole-3-Propionic Acid (IPA)
- Produced primarily by Clostridium sporogenes via the reductive tryptophan pathway.
- Potent AhR agonist and antioxidant; neuroprotective. Reduced in cerebrospinal fluid of Parkinson's patients.
- Systemic effects: scavenges hydroxyl radicals, reduces intestinal permeability, anti-inflammatory in CNS.
Indole-3-Aldehyde (3-IAld)
- Produced by lactobacillus species via aromatic amino acid aminotransferases.
- Strong AhR activator; promotes IL-22 production by ILC3 cells; antifungal defense at mucosal surfaces.
Indole-3-Acetic Acid (IAA)
- Produced by multiple gut bacteria from tryptophan; also a major plant growth hormone (auxin).
- AhR ligand; increased significantly under ketogenic diet in MS patients, correlating with reduced neuroinflammatory lesions [1].
Tryptamine
- Produced by decarboxylation of tryptophan by Clostridium sporogenes and Ruminococcus gnavus.
- Activates serotonin receptor 5-HT4R on colonocytes, promoting intestinal motility and fluid secretion [2].
The AhR Axis
Indole metabolites converge on the aryl hydrocarbon receptor, which:
- Drives IL-22 production (mucosal barrier repair, antimicrobial peptides).
- Suppresses Th17 differentiation while promoting Treg and Tr1 cells.
- Modulates microglial activation in the CNS, reducing neuroinflammation.
- Maintains intestinal stem cell homeostasis.
The AhR pathway represents a key mechanism by which the gut microbiome communicates with the immune system and the brain via the gut brain axis.
Disease Relevance
- Multiple sclerosis: Ketogenic diet shifts tryptophan metabolism from kynurenine toward indoles (IAA, ILA); higher indole/Trp ratios associated with fewer MRI lesions [1].
- Autism spectrum disorder: Indole derivatives depleted; p-cresol and 4-EPS (from competing aromatic AA pathways) elevated instead. FMT reduced indole pathway disruption [3].
- IBD: Reduced indole production due to loss of Clostridium sporogenes and Lactobacillus; impaired AhR-IL-22 axis weakens barrier repair.
- Cardiovascular disease: Indoxyl sulfate (a host-modified indole derivative) is a uremic toxin promoting endothelial dysfunction and atherosclerosis.
- CKD: Indoxyl sulfate accumulates due to impaired renal clearance; drives renal fibrosis and cardiovascular complications.
Metal Connections
Heavy metal-induced dysbiosis depletes the SCFA producers and Lactobacillus/Clostridium species that generate protective indoles. This shifts tryptophan metabolism toward the inflammatory kynurenine pathway (whose rate-limiting enzymes IDO/TDO require iron), reducing AhR-mediated mucosal protection. The result is a double hit: less barrier repair and more neurotoxic kynurenine metabolites.
See Also
- tryptophan metabolism — full pathway overview including kynurenine and serotonin branches
- short chain fatty acids — parallel microbiome-derived protective metabolites
- gut brain axis — neuroimmune signaling route for indole effects